Consent and liability: Special problems with anxiolytics

M. J. Mills, Spencer Eth

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The use of benzodiazepine anxiolytic therapy has sometimes been associated with certain adverse reactions. The authors discuss the extent to which the clinician is responsible for warning patients that benzodiazepine therapy may result in addiction, withdrawal problems, and/or impaired cognitive and motor skills. The development of new anxiolytics such as buspirone, which seem to exert less effect on cognitive and motor skills and lack addiction potential (and thus withdrawal problems), presents the clinician with a treatment alternative. The authors review two legal cases involving benzodiazepine-induced driving impairment and discuss whether the clinician is obligated to prescribe the agent that generally demonstrates the least interference with such common activities as driving. Primary issues that arise in the discussion of physician responsibility are informed consent (both verbal and written) and the documentation of all treatment decisions. The authors recommend quality care and individualized treatment to avoid liability.

Original languageEnglish
Pages (from-to)29-32
Number of pages4
JournalJournal of Clinical Psychiatry
Volume48
Issue numberSUPPL. DEC
StatePublished - Dec 1 1987
Externally publishedYes

Fingerprint

Anti-Anxiety Agents
Benzodiazepines
Motor Skills
Buspirone
Therapeutics
Quality of Health Care
Informed Consent
Documentation
Physicians

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Consent and liability : Special problems with anxiolytics. / Mills, M. J.; Eth, Spencer.

In: Journal of Clinical Psychiatry, Vol. 48, No. SUPPL. DEC, 01.12.1987, p. 29-32.

Research output: Contribution to journalArticle

@article{1e91d4b63352433da139188762eeb4ba,
title = "Consent and liability: Special problems with anxiolytics",
abstract = "The use of benzodiazepine anxiolytic therapy has sometimes been associated with certain adverse reactions. The authors discuss the extent to which the clinician is responsible for warning patients that benzodiazepine therapy may result in addiction, withdrawal problems, and/or impaired cognitive and motor skills. The development of new anxiolytics such as buspirone, which seem to exert less effect on cognitive and motor skills and lack addiction potential (and thus withdrawal problems), presents the clinician with a treatment alternative. The authors review two legal cases involving benzodiazepine-induced driving impairment and discuss whether the clinician is obligated to prescribe the agent that generally demonstrates the least interference with such common activities as driving. Primary issues that arise in the discussion of physician responsibility are informed consent (both verbal and written) and the documentation of all treatment decisions. The authors recommend quality care and individualized treatment to avoid liability.",
author = "Mills, {M. J.} and Spencer Eth",
year = "1987",
month = "12",
day = "1",
language = "English",
volume = "48",
pages = "29--32",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "SUPPL. DEC",

}

TY - JOUR

T1 - Consent and liability

T2 - Special problems with anxiolytics

AU - Mills, M. J.

AU - Eth, Spencer

PY - 1987/12/1

Y1 - 1987/12/1

N2 - The use of benzodiazepine anxiolytic therapy has sometimes been associated with certain adverse reactions. The authors discuss the extent to which the clinician is responsible for warning patients that benzodiazepine therapy may result in addiction, withdrawal problems, and/or impaired cognitive and motor skills. The development of new anxiolytics such as buspirone, which seem to exert less effect on cognitive and motor skills and lack addiction potential (and thus withdrawal problems), presents the clinician with a treatment alternative. The authors review two legal cases involving benzodiazepine-induced driving impairment and discuss whether the clinician is obligated to prescribe the agent that generally demonstrates the least interference with such common activities as driving. Primary issues that arise in the discussion of physician responsibility are informed consent (both verbal and written) and the documentation of all treatment decisions. The authors recommend quality care and individualized treatment to avoid liability.

AB - The use of benzodiazepine anxiolytic therapy has sometimes been associated with certain adverse reactions. The authors discuss the extent to which the clinician is responsible for warning patients that benzodiazepine therapy may result in addiction, withdrawal problems, and/or impaired cognitive and motor skills. The development of new anxiolytics such as buspirone, which seem to exert less effect on cognitive and motor skills and lack addiction potential (and thus withdrawal problems), presents the clinician with a treatment alternative. The authors review two legal cases involving benzodiazepine-induced driving impairment and discuss whether the clinician is obligated to prescribe the agent that generally demonstrates the least interference with such common activities as driving. Primary issues that arise in the discussion of physician responsibility are informed consent (both verbal and written) and the documentation of all treatment decisions. The authors recommend quality care and individualized treatment to avoid liability.

UR - http://www.scopus.com/inward/record.url?scp=0023600705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023600705&partnerID=8YFLogxK

M3 - Article

C2 - 2891687

AN - SCOPUS:0023600705

VL - 48

SP - 29

EP - 32

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - SUPPL. DEC

ER -